211 related articles for article (PubMed ID: 30087366)
81. Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact.
Leivonen SK; Rokka A; Ostling P; Kohonen P; Corthals GL; Kallioniemi O; Perälä M
Mol Cell Proteomics; 2011 Jul; 10(7):M110.005322. PubMed ID: 21512034
[TBL] [Abstract][Full Text] [Related]
82. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
[TBL] [Abstract][Full Text] [Related]
83. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
[TBL] [Abstract][Full Text] [Related]
84. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
85. Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.
Xiang Y; Lu DL; Li JP; Yu CX; Zheng DL; Huang X; Wang ZY; Hu P; Liao XH; Zhang TC
IUBMB Life; 2016 Jun; 68(6):477-87. PubMed ID: 27156566
[TBL] [Abstract][Full Text] [Related]
86. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
[TBL] [Abstract][Full Text] [Related]
87. Mediator subunits MED1 and MED24 cooperatively contribute to pubertal mammary gland development and growth of breast carcinoma cells.
Hasegawa N; Sumitomo A; Fujita A; Aritome N; Mizuta S; Matsui K; Ishino R; Inoue K; Urahama N; Nose J; Mukohara T; Kamoshida S; Roeder RG; Ito M
Mol Cell Biol; 2012 Apr; 32(8):1483-95. PubMed ID: 22331469
[TBL] [Abstract][Full Text] [Related]
88. Loss of Estrogen-Regulated
Zhang W; Wu M; Chong QY; Zhang M; Zhang X; Hu L; Zhong Y; Qian P; Kong X; Tan S; Li G; Ding K; Lobie PE; Zhu T
Cancer Res; 2018 Sep; 78(17):4915-4928. PubMed ID: 29945962
[TBL] [Abstract][Full Text] [Related]
89. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152.
Li Z; Li Y; Li Y; Ren K; Li X; Han X; Wang J
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544374
[TBL] [Abstract][Full Text] [Related]
90. NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p.
Chen H; Yu C; Shen L; Wu Y; Wu D; Wang Z; Song G; Chen L; Hong Y
Pathol Res Pract; 2020 Dec; 216(12):153236. PubMed ID: 33038688
[TBL] [Abstract][Full Text] [Related]
91. R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.
Boldes T; Merenbakh-Lamin K; Journo S; Shachar E; Lipson D; Yeheskel A; Pasmanik-Chor M; Rubinek T; Wolf I
BMC Cancer; 2020 Jun; 20(1):531. PubMed ID: 32513126
[TBL] [Abstract][Full Text] [Related]
92. miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.
Ben-Elazar S; Aure MR; Jonsdottir K; Leivonen SK; Kristensen VN; Janssen EAM; Kleivi Sahlberg K; Lingjærde OC; Yakhini Z
PLoS Comput Biol; 2021 Feb; 17(2):e1008608. PubMed ID: 33566819
[TBL] [Abstract][Full Text] [Related]
93. Modulation of estrogen receptor alpha activity and expression during breast cancer progression.
Kerdivel G; Flouriot G; Pakdel F
Vitam Horm; 2013; 93():135-60. PubMed ID: 23810005
[TBL] [Abstract][Full Text] [Related]
94. Establishment of a cell-type-specific genetic network by the mediator complex component Med1.
Pope NJ; Bresnick EH
Mol Cell Biol; 2013 May; 33(10):1938-55. PubMed ID: 23459945
[TBL] [Abstract][Full Text] [Related]
95. Med1 plays a critical role in the development of tamoxifen resistance.
Nagalingam A; Tighiouart M; Ryden L; Joseph L; Landberg G; Saxena NK; Sharma D
Carcinogenesis; 2012 Apr; 33(4):918-30. PubMed ID: 22345290
[TBL] [Abstract][Full Text] [Related]
96. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA.
Pandey DP; Picard D
Mol Cell Biol; 2009 Jul; 29(13):3783-90. PubMed ID: 19414598
[TBL] [Abstract][Full Text] [Related]
97. MiR-205 silences MED1 in hypoxic primary human trophoblasts.
Mouillet JF; Chu T; Nelson DM; Mishima T; Sadovsky Y
FASEB J; 2010 Jun; 24(6):2030-9. PubMed ID: 20065103
[TBL] [Abstract][Full Text] [Related]
98. miR-500a-5p regulates oxidative stress response genes in breast cancer and predicts cancer survival.
Degli Esposti D; Aushev VN; Lee E; Cros MP; Zhu J; Herceg Z; Chen J; Hernandez-Vargas H
Sci Rep; 2017 Nov; 7(1):15966. PubMed ID: 29162888
[TBL] [Abstract][Full Text] [Related]
99. Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer.
Yang Y; Leonard M; Luo Z; Yeo S; Bick G; Hao M; Cai C; Charif M; Wang J; Guan JL; Lower EE; Zhang X
Cell Rep; 2021 Mar; 34(10):108822. PubMed ID: 33691110
[TBL] [Abstract][Full Text] [Related]
100. Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.
Duex JE; Comeau L; Sorkin A; Purow B; Kefas B
J Biol Chem; 2011 Jul; 286(28):25377-86. PubMed ID: 21592959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
